Copyright Reports & Markets. All rights reserved.

Global and China PCR-based Enteric Disease Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global PCR-based Enteric Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Analyzers/Instruments
    • 1.2.3 Kits/Panels
  • 1.3 Market by Application
    • 1.3.1 Global PCR-based Enteric Disease Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Clostridium Difficile
    • 1.3.3 Campylobacteriosis
    • 1.3.4 Cholera
    • 1.3.5 E. coli Infection
    • 1.3.6 H. pylori Infection
    • 1.3.7 Salmonellosis
    • 1.3.8 Shigellosis
    • 1.3.9 Rotavirus Infection
    • 1.3.10 Norovirus Infection
    • 1.3.11 Parasitic Enteric Disease
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global PCR-based Enteric Disease Testing Market Perspective (2015-2026)
  • 2.2 Global PCR-based Enteric Disease Testing Growth Trends by Regions
    • 2.2.1 PCR-based Enteric Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 PCR-based Enteric Disease Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 PCR-based Enteric Disease Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top PCR-based Enteric Disease Testing Players by Market Size
    • 3.1.1 Global Top PCR-based Enteric Disease Testing Players by Revenue (2015-2020)
    • 3.1.2 Global PCR-based Enteric Disease Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global PCR-based Enteric Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by PCR-based Enteric Disease Testing Revenue
  • 3.4 Global PCR-based Enteric Disease Testing Market Concentration Ratio
    • 3.4.1 Global PCR-based Enteric Disease Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by PCR-based Enteric Disease Testing Revenue in 2019
  • 3.5 Key Players PCR-based Enteric Disease Testing Area Served
  • 3.6 Key Players PCR-based Enteric Disease Testing Product Solution and Service
  • 3.7 Date of Enter into PCR-based Enteric Disease Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 PCR-based Enteric Disease Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global PCR-based Enteric Disease Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Type (2021-2026)

5 PCR-based Enteric Disease Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global PCR-based Enteric Disease Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global PCR-based Enteric Disease Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America PCR-based Enteric Disease Testing Market Size (2015-2026)
  • 6.2 North America PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
  • 6.3 North America PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
  • 6.4 North America PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe PCR-based Enteric Disease Testing Market Size (2015-2026)
  • 7.2 Europe PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
  • 7.3 Europe PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
  • 7.4 Europe PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China PCR-based Enteric Disease Testing Market Size (2015-2026)
  • 8.2 China PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
  • 8.3 China PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
  • 8.4 China PCR-based Enteric Disease Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan PCR-based Enteric Disease Testing Market Size (2015-2026)
  • 9.2 Japan PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
  • 9.3 Japan PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
  • 9.4 Japan PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia PCR-based Enteric Disease Testing Market Size (2015-2026)
  • 10.2 Southeast Asia PCR-based Enteric Disease Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia PCR-based Enteric Disease Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia PCR-based Enteric Disease Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific PCR-based Enteric Disease Testing Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in PCR-based Enteric Disease Testing Business (2015-2020))
    • 11.1.5 Thermo Fisher Scientific Recent Development
  • 11.2 Vela Diagnostics
    • 11.2.1 Vela Diagnostics Company Details
    • 11.2.2 Vela Diagnostics Business Overview
    • 11.2.3 Vela Diagnostics PCR-based Enteric Disease Testing Introduction
    • 11.2.4 Vela Diagnostics Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.2.5 Vela Diagnostics Recent Development
  • 11.3 CorisBioconcept
    • 11.3.1 CorisBioconcept Company Details
    • 11.3.2 CorisBioconcept Business Overview
    • 11.3.3 CorisBioconcept PCR-based Enteric Disease Testing Introduction
    • 11.3.4 CorisBioconcept Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.3.5 CorisBioconcept Recent Development
  • 11.4 Meridian Life Science
    • 11.4.1 Meridian Life Science Company Details
    • 11.4.2 Meridian Life Science Business Overview
    • 11.4.3 Meridian Life Science PCR-based Enteric Disease Testing Introduction
    • 11.4.4 Meridian Life Science Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.4.5 Meridian Life Science Recent Development
  • 11.5 Bio-Rad Laboratories
    • 11.5.1 Bio-Rad Laboratories Company Details
    • 11.5.2 Bio-Rad Laboratories Business Overview
    • 11.5.3 Bio-Rad Laboratories PCR-based Enteric Disease Testing Introduction
    • 11.5.4 Bio-Rad Laboratories Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.5.5 Bio-Rad Laboratories Recent Development
  • 11.6 Abbott (ALERE)
    • 11.6.1 Abbott (ALERE) Company Details
    • 11.6.2 Abbott (ALERE) Business Overview
    • 11.6.3 Abbott (ALERE) PCR-based Enteric Disease Testing Introduction
    • 11.6.4 Abbott (ALERE) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.6.5 Abbott (ALERE) Recent Development
  • 11.7 bioMerieux SA
    • 11.7.1 bioMerieux SA Company Details
    • 11.7.2 bioMerieux SA Business Overview
    • 11.7.3 bioMerieux SA PCR-based Enteric Disease Testing Introduction
    • 11.7.4 bioMerieux SA Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.7.5 bioMerieux SA Recent Development
  • 11.8 Trinity Biotech
    • 11.8.1 Trinity Biotech Company Details
    • 11.8.2 Trinity Biotech Business Overview
    • 11.8.3 Trinity Biotech PCR-based Enteric Disease Testing Introduction
    • 11.8.4 Trinity Biotech Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.8.5 Trinity Biotech Recent Development
  • 11.9 DiaSorin Molecular
    • 11.9.1 DiaSorin Molecular Company Details
    • 11.9.2 DiaSorin Molecular Business Overview
    • 11.9.3 DiaSorin Molecular PCR-based Enteric Disease Testing Introduction
    • 11.9.4 DiaSorin Molecular Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.9.5 DiaSorin Molecular Recent Development
  • 11.10 Etta Healthcare (Ovagene Oncology)
    • 11.10.1 Etta Healthcare (Ovagene Oncology) Company Details
    • 11.10.2 Etta Healthcare (Ovagene Oncology) Business Overview
    • 11.10.3 Etta Healthcare (Ovagene Oncology) PCR-based Enteric Disease Testing Introduction
    • 11.10.4 Etta Healthcare (Ovagene Oncology) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 11.10.5 Etta Healthcare (Ovagene Oncology) Recent Development
  • 11.11 ExcitePCR (PositiveID Corporation)
    • 10.11.1 ExcitePCR (PositiveID Corporation) Company Details
    • 10.11.2 ExcitePCR (PositiveID Corporation) Business Overview
    • 10.11.3 ExcitePCR (PositiveID Corporation) PCR-based Enteric Disease Testing Introduction
    • 10.11.4 ExcitePCR (PositiveID Corporation) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.11.5 ExcitePCR (PositiveID Corporation) Recent Development
  • 11.12 Flow Alliance
    • 10.12.1 Flow Alliance Company Details
    • 10.12.2 Flow Alliance Business Overview
    • 10.12.3 Flow Alliance PCR-based Enteric Disease Testing Introduction
    • 10.12.4 Flow Alliance Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.12.5 Flow Alliance Recent Development
  • 11.13 Fluid-Screen
    • 10.13.1 Fluid-Screen Company Details
    • 10.13.2 Fluid-Screen Business Overview
    • 10.13.3 Fluid-Screen PCR-based Enteric Disease Testing Introduction
    • 10.13.4 Fluid-Screen Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.13.5 Fluid-Screen Recent Development
  • 11.14 FluimediX
    • 10.14.1 FluimediX Company Details
    • 10.14.2 FluimediX Business Overview
    • 10.14.3 FluimediX PCR-based Enteric Disease Testing Introduction
    • 10.14.4 FluimediX Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.14.5 FluimediX Recent Development
  • 11.15 Fluxergy
    • 10.15.1 Fluxergy Company Details
    • 10.15.2 Fluxergy Business Overview
    • 10.15.3 Fluxergy PCR-based Enteric Disease Testing Introduction
    • 10.15.4 Fluxergy Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.15.5 Fluxergy Recent Development
  • 11.16 Focus Diagnostics (DiaSorin Molecular)
    • 10.16.1 Focus Diagnostics (DiaSorin Molecular) Company Details
    • 10.16.2 Focus Diagnostics (DiaSorin Molecular) Business Overview
    • 10.16.3 Focus Diagnostics (DiaSorin Molecular) PCR-based Enteric Disease Testing Introduction
    • 10.16.4 Focus Diagnostics (DiaSorin Molecular) Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.16.5 Focus Diagnostics (DiaSorin Molecular) Recent Development
  • 11.17 Future Horizon Scientific
    • 10.17.1 Future Horizon Scientific Company Details
    • 10.17.2 Future Horizon Scientific Business Overview
    • 10.17.3 Future Horizon Scientific PCR-based Enteric Disease Testing Introduction
    • 10.17.4 Future Horizon Scientific Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.17.5 Future Horizon Scientific Recent Development
  • 11.18 Genalyte
    • 10.18.1 Genalyte Company Details
    • 10.18.2 Genalyte Business Overview
    • 10.18.3 Genalyte PCR-based Enteric Disease Testing Introduction
    • 10.18.4 Genalyte Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.18.5 Genalyte Recent Development
  • 11.19 GeneFluidics
    • 10.19.1 GeneFluidics Company Details
    • 10.19.2 GeneFluidics Business Overview
    • 10.19.3 GeneFluidics PCR-based Enteric Disease Testing Introduction
    • 10.19.4 GeneFluidics Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.19.5 GeneFluidics Recent Development
  • 11.20 GenSpeed Biotech
    • 10.20.1 GenSpeed Biotech Company Details
    • 10.20.2 GenSpeed Biotech Business Overview
    • 10.20.3 GenSpeed Biotech PCR-based Enteric Disease Testing Introduction
    • 10.20.4 GenSpeed Biotech Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.20.5 GenSpeed Biotech Recent Development
  • 11.21 Gulf Bio Analytical
    • 10.21.1 Gulf Bio Analytical Company Details
    • 10.21.2 Gulf Bio Analytical Business Overview
    • 10.21.3 Gulf Bio Analytical PCR-based Enteric Disease Testing Introduction
    • 10.21.4 Gulf Bio Analytical Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.21.5 Gulf Bio Analytical Recent Development
  • 11.22 Hahn-Schickard
    • 10.22.1 Hahn-Schickard Company Details
    • 10.22.2 Hahn-Schickard Business Overview
    • 10.22.3 Hahn-Schickard PCR-based Enteric Disease Testing Introduction
    • 10.22.4 Hahn-Schickard Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.22.5 Hahn-Schickard Recent Development
  • 11.23 Helvoet
    • 10.23.1 Helvoet Company Details
    • 10.23.2 Helvoet Business Overview
    • 10.23.3 Helvoet PCR-based Enteric Disease Testing Introduction
    • 10.23.4 Helvoet Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.23.5 Helvoet Recent Development
  • 11.24 HemoCue
    • 10.24.1 HemoCue Company Details
    • 10.24.2 HemoCue Business Overview
    • 10.24.3 HemoCue PCR-based Enteric Disease Testing Introduction
    • 10.24.4 HemoCue Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.24.5 HemoCue Recent Development
  • 11.25 Danaher
    • 10.25.1 Danaher Company Details
    • 10.25.2 Danaher Business Overview
    • 10.25.3 Danaher PCR-based Enteric Disease Testing Introduction
    • 10.25.4 Danaher Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.25.5 Danaher Recent Development
  • 11.26 IDEX Health&Science
    • 10.26.1 IDEX Health&Science Company Details
    • 10.26.2 IDEX Health&Science Business Overview
    • 10.26.3 IDEX Health&Science PCR-based Enteric Disease Testing Introduction
    • 10.26.4 IDEX Health&Science Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.26.5 IDEX Health&Science Recent Development
  • 11.27 iLine Microsystems
    • 10.27.1 iLine Microsystems Company Details
    • 10.27.2 iLine Microsystems Business Overview
    • 10.27.3 iLine Microsystems PCR-based Enteric Disease Testing Introduction
    • 10.27.4 iLine Microsystems Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.27.5 iLine Microsystems Recent Development
  • 11.28 Inflammatix
    • 10.28.1 Inflammatix Company Details
    • 10.28.2 Inflammatix Business Overview
    • 10.28.3 Inflammatix PCR-based Enteric Disease Testing Introduction
    • 10.28.4 Inflammatix Revenue in PCR-based Enteric Disease Testing Business (2015-2020)
    • 10.28.5 Inflammatix Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global PCR-based Enteric Disease Testing Scope and Market Size
    PCR-based Enteric Disease Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PCR-based Enteric Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Analyzers/Instruments
    Kits/Panels

    Market segment by Application, split into
    Clostridium Difficile
    Campylobacteriosis
    Cholera
    E. coli Infection
    H. pylori Infection
    Salmonellosis
    Shigellosis
    Rotavirus Infection
    Norovirus Infection

    Based on regional and country-level analysis, the PCR-based Enteric Disease Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global PCR-based Enteric Disease Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Thermo Fisher Scientific
    Vela Diagnostics
    CorisBioconcept
    Meridian Life Science
    Bio-Rad Laboratories
    Abbott (ALERE)
    bioMerieux SA
    Trinity Biotech
    DiaSorin Molecular
    Etta Healthcare (Ovagene Oncology)
    ExcitePCR (PositiveID Corporation)
    Flow Alliance
    Fluid-Screen
    FluimediX
    Fluxergy
    Focus Diagnostics (DiaSorin Molecular)
    Future Horizon Scientific
    Genalyte
    GeneFluidics
    GenSpeed Biotech
    Gulf Bio Analytical
    Hahn-Schickard
    Helvoet
    HemoCue
    Danaher
    IDEX Health&Science
    iLine Microsystems
    Inflammatix

    Buy now